Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma

Cameron, 2006, One thousand consecutive pancreaticoduodenectomies, Ann Surg, 244, 10, 10.1097/01.sla.0000217673.04165.ea

Sohn, 2000, Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators, J Gastrointest Surg, 4, 567, 10.1016/S1091-255X(00)80105-5

Oettle, 2007, Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial, JAMA, 297, 267, 10.1001/jama.297.3.267

Ueno, 2009, A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer, Br J Cancer, 101, 908, 10.1038/sj.bjc.6605256

Klinkenbijl, 1999, Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group, Ann Surg, 230, 776, 10.1097/00000658-199912000-00006

Seiler, 2005, Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results, Br J Surg, 92, 547, 10.1002/bjs.4881

Balzano, 2008, Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy, Br J Surg, 95, 357, 10.1002/bjs.5982

Balcom JHt, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 2001;136(4): 391–8.

Pratt, 2008, POSSUM accurately predicts morbidity for pancreatic resection, Surgery, 143, 8, 10.1016/j.surg.2007.07.035

Emick DM, Riall TS, Cameron JL, et al. Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg 2006;10(9): 1243–52; discussion 52–3.

Pratt, 2007, Clinical and economic validation of the International Study Group of Pancreatic Fistula (ISGPF) classification scheme, Ann Surg, 245, 443, 10.1097/01.sla.0000251708.70219.d2

Pawlik, 2007, Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer, Surgery, 141, 610, 10.1016/j.surg.2006.12.013

Slidell, 2008, Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis, Annals of surgical oncology, 15, 165, 10.1245/s10434-007-9587-1

Asiyanbola, 2009, Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 13, 752, 10.1007/s11605-008-0762-x

Deyle S, Banz VM, Wagner M, et al. Estimation of physiologic ability and surgical stress score does not predict immediate outcome after pancreatic surgery. Pancreas;40(5): 723–9.

Hashimoto D, Takamori H, Sakamoto Y, Tanaka H, Hirota M, Baba H. Can the physiologic ability and surgical stress (E-PASS) scoring system predict operative morbidity after distal pancreatectomy? Surg Today;40(7): 632–7.

Hashimoto D, Takamori H, Sakamoto Y, et al. Is an estimation of physiologic ability and surgical stress able to predict operative morbidity after pancreaticoduodenectomy? J Hepatobiliary Pancreat Sci;17(2): 132-8.

Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg;210(6): 901–8.

Peng PD, van Vledder MG, Tsai S, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford);13(7): 439–46.

Prado, 2009, The emerging role of computerized tomography in assessing cancer cachexia, Curr Opin Support Palliat Care, 3, 269, 10.1097/SPC.0b013e328331124a

Prado, 2009, Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment, Clin Cancer Res, 15, 2920, 10.1158/1078-0432.CCR-08-2242

Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol;28(2): 340–7.

Antoun S, Baracos VE, Birdsell L, Escudier B, Sawyer MB. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol;21(8): 1594–8.

Antoun S, Birdsell L, Sawyer MB, Venner P, Escudier B, Baracos VE. Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study. J Clin Oncol;28(6): 1054–60.

Tan, 2009, Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer, Clin Cancer Res, 15, 6973, 10.1158/1078-0432.CCR-09-1525

Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, Wang S. Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma. Ann Surg Oncol;18(13): 3579–85.

Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg;211(2): 271–8.

Clavien, 2009, The Clavien-Dindo classification of surgical complications: five-year experience, Ann Surg, 250, 187, 10.1097/SLA.0b013e3181b13ca2

Baumgartner, 1998, Epidemiology of sarcopenia among the elderly in New Mexico, Am J Epidemiol, 147, 755, 10.1093/oxfordjournals.aje.a009520

Shen, 2004, Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image, J Appl Physiol, 97, 2333, 10.1152/japplphysiol.00744.2004

Mourtzakis, 2008, A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care, Appl Physiol Nutr Metab, 33, 997, 10.1139/H08-075

van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. The British journal of surgery 2012.

Dodson, 2011, Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies, Annual review of medicine, 62, 265, 10.1146/annurev-med-061509-131248

Fearon, 2006, Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis, The American journal of clinical nutrition, 83, 1345, 10.1093/ajcn/83.6.1345

Blum D, Omlin A, Fearon K, et al. Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer;18(3): 273–9.

Ockenga, 2005, Review article: anorexia and cachexia in gastrointestinal cancer, Aliment Pharmacol Ther, 22, 583, 10.1111/j.1365-2036.2005.02628.x

Fouladiun, 2005, Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care—correlations with food intake, metabolism, exercise capacity, and hormones, Cancer, 103, 2189, 10.1002/cncr.21013

Goodpaster, 2006, The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study, J Gerontol A Biol Sci Med Sci, 61, 1059, 10.1093/gerona/61.10.1059

Park, 2009, Excessive loss of skeletal muscle mass in older adults with type 2 diabetes, Diabetes Care, 32, 1993, 10.2337/dc09-0264

Park, 2007, Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study, Diabetes Care, 30, 1507, 10.2337/dc06-2537

Baracos, 2010, Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis, The American journal of clinical nutrition, 91, 1133S, 10.3945/ajcn.2010.28608C